Mitochondrial dysfunction–ferroptosis crosstalk drives renal fibrosis in chronic kidney disease

Key Points

• The study investigates how mitochondrial dysfunction and ferroptosis contribute to renal fibrosis in chronic kidney disease.
• Examined the mechanisms of mitochondrial dysfunction and ferroptosis in renal cells.
• Assessments of antioxidant defense and Nrf2 signaling impacts.
• Modulated mitochondrial quality control through mitophagy interventions.
• Mitochondrial dysfunction significantly activates ferroptosis pathways, contributing to renal fibrosis.
• Enhancement of Nrf2 signaling improved antioxidant defense and reduced fibrosis markers.
• Mitophagy modulation showed a marked decrease in renal scarring and improved renal function.